Definitive Contract HR001120C0073
Award Date
9/16/20
Potential Completion Date
6/17/22
Potential Value
$15M
Federal Agency
Defense Advanced Research Projects Agency
Awardee
Ginkgo Bioworks, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,797,261 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston. The contract is for DARPA's "SUPERB: SYNBIO + UNIVERSAL PURIFICATION OF EXTRACT-DERIVED, RIGHT-ON-TIME BIOLOGICS" program, which aims to develop technologies enabling immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week....
This federal contract award from the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, has a total ceiling value of $10,446,304.00. The purpose of this Cost Plus Fixed Fee contract is to have Ginkgo Bioworks serve as a TA3 SD2 performer, developing software interfaces to transition generated synthetic biological test results to other software systems as part of the GINKGO BIOWORKS SD2 PROGRAM. This contract is not set aside for...
This is a $12,045,252.00 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a Boston-based biotechnology company. The contract is for the "ICE CONTROL FOR COLD ENVIRONMENTS (ICE)" program, which seeks to develop biologically-sourced or inspired molecules to inhibit ice crystallization, propagation, and adhesion to mitigate extreme cold weather challenges for Department of Defense (DoD) applications. The original...
<p>This is a $1,509,952.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to All Things Bugs LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for new technology and genetically engineered insects for sustainable food, nutrition, health, and other applications. The contract has an ultimate completion date of August 24, 2021 and was awarded on June 25, 2018.</p>
This is a $3,999,210.00 cost-plus-fixed-fee definitive contract awarded by the Department of the Navy Information Warfare Systems Command to Ginkgo Bioworks, Inc., a biotechnology firm based in Boston, for the DNA Recording Intrinsic Cellular Biointelligence (DRINC BIO) project. The contract has a completion date of May 21, 2025 and was awarded on May 2, 2023 with no set-aside designation. Ginkgo Bioworks provides research, testing, and production services related to cellular engineering, DNA...
This is a Cost Plus Fixed Fee contract awarded by the Navy NAVSUP Engineering Logistics Office to Ginkgo Bioworks, Inc., a Boston-based biotechnology company, for the IARPA FELIX PROGRAM. The contract has a ceiling value of $5,338,550.00 and a completion date of June 30, 2022. Ginkgo Bioworks is a for-profit manufacturer of goods that specializes in cellular engineering, DNA sequencing, and advanced biological manufacturing services. The company has a proven track record of delivering complex...
This $50,216,772.13 Firm Fixed Price Delivery Order contract was awarded to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract is for test surge and data sharing services under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle held with the Centers for Disease Control and Prevention (CDC). The IDIQ has a total ceiling value of $118 million and an ultimate completion date of September 5, 2029. Ginkgo Bioworks has previously provided...
This is a $1,205,149.24 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The contract, titled "TRAVELER-BASED GENOMIC SURVEILLANCE," is for the provision of biotechnology services to support the CDC's public health monitoring and emergency response initiatives. The contract has an ultimate completion date of September 19, 2024 and was awarded on August 26, 2024....
This is a definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to MRIGlobal, a 501(c)(3) not-for-profit research organization. The $37,048,565 cost-plus-fixed-fee contract is for research in support of DARPA's DIGET program, without any set-aside designation. MRIGlobal has subcontracted with several vendors, including Integrated DNA Technologies (IDT), Applied Microarrays, LLC, Natech Plastics Inc., The Charles Stark Draper Laboratory, Inc., University of...
This is a $794,734 firm fixed-price definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Phylagen, Inc. for the "Biological Robustness in Complex Settings Program - Tracking Maritime Vessels through Microbiome Surveillance" project. The contract has an ultimate completion date of September 4, 2017 and does not have a set-aside designation. The contract is focused on leveraging microbiome surveillance to track maritime vessels, which aligns with...